Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor.
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Advances in Drug Discovery and Evaluation for the Treatment of Affective Disorders and Schizophrenia (Deadline: 20 April 2024)
- Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma 2024 (Deadline: 20 April 2024)
- Recent Advances in the Pharmacology of Serotonin and Its Receptors (Deadline: 20 April 2024)
- Targeting Apoptosis as a Strategy for Developing New Drugs (Deadline: 20 April 2024)
- Pharmacovigilance in Drug Therapy: Drug–Drug Interactions and Safety Evaluation (Deadline: 25 April 2024)
- New Perspectives in Ocular Pharmacology (Deadline: 25 April 2024)
- Metformin: Mechanism and Application 2023 (Deadline: 25 April 2024)
- Therapeutic Potential for Cannabinoid and Its Receptor (Deadline: 25 April 2024)
- Potassium Channels as Novel Therapeutic Targets (Deadline: 25 April 2024)
- Psychopharmacology: Recent Advances (Deadline: 30 April 2024)
- Novel Target for Pharmacological Treatment of Epilepsy (Deadline: 30 April 2024)
- Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2023 (Deadline: 30 April 2024)
- Recent Advances in Psychopharmacology (Deadline: 30 April 2024)
- Inflammatory Cytokines as New Therapeutic Targets (Deadline: 30 April 2024)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success (Deadline: 30 April 2024)
- Antidepressant Drug (Deadline: 30 April 2024)
- Novel Therapeutic Target for Hepatocellular Carcinoma (Deadline: 30 April 2024)
- Pharmacotherapy of Neurodegeneration Disorders (Deadline: 30 April 2024)
- Cancer Treatment Toxicities: Molecular Insights and Novel Therapeutic Approaches (Deadline: 30 April 2024)
- Chemokines and Chemokine Receptors (Deadline: 30 April 2024)
- Current Frames on Cardiotoxicology of New and Old Anticancer Drugs (Deadline: 8 May 2024)
- Therapeutic Target Developments in Pancreatic Cancer (Deadline: 12 May 2024)
- Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease (Deadline: 15 May 2024)
- Novel Therapeutic Approaches for Cystic Fibrosis (Deadline: 20 May 2024)
- From Bench to Bedside: Expanding the Scope of Thioredoxin Reductase Inhibitors as Promising Therapeutics for Tumors, Inflammatory Disorders, and Infectious Diseases (Deadline: 20 May 2024)
- Purinergic Receptors and Ectonucleotidases as Novel Therapeutic Targets (Deadline: 22 May 2024)
- Potential Therapeutic Targets for the Treatment of Pathological Pain (Deadline: 24 May 2024)
- Recent Advances and Perspectives in the Treatment of Dementia (Deadline: 25 May 2024)
- Stem Cell Therapies in the Fight of Amyotrophic Lateral Sclerosis (Deadline: 25 May 2024)
- NeuroImmunoEndocrinology (Deadline: 25 May 2024)
- Drug Therapy for Glioma (Deadline: 25 May 2024)
- Pharmacotherapy for Retinopathy (Deadline: 25 May 2024)
- New Advances in Antiarrhythmic Drugs (Deadline: 25 May 2024)
- Pharmacology and Toxicology of Opioids (Deadline: 31 May 2024)
- Therapeutic Targets and Therapies in Graft versus Host Disease (GVHD) (Deadline: 31 May 2024)
- New Targets and Experimental Therapeutic Approaches for Cancers (Deadline: 31 May 2024)
- Innovative Tools for Drug Analysis and Therapeutic Drug Monitoring (TDM) (Deadline: 31 May 2024)
- Infectious Disease Epidemiology and Pharmaceutical Development (Deadline: 31 May 2024)
- Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects 2023 (Deadline: 31 May 2024)
- Recent Advances in TGF-β Inhibitors for the Therapeutic Management of Cancer and Fibrosis (Deadline: 31 May 2024)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology (Deadline: 20 June 2024)
- Therapeutics for Ferroptosis in CNS Disease (Deadline: 20 June 2024)
- Data-Driven Biomarker and Drug Discovery for Complex Disease (Deadline: 20 June 2024)
- New Approaches for the Prevention and Alleviation of Metabolic Syndrome 2024 (Deadline: 20 June 2024)
- Pharmacotherapy of Neuropathic Pain (Deadline: 20 June 2024)
- Current Therapies for Endometriosis, Adenomyosis and Endometrial Cancer (Deadline: 22 June 2024)
- Long Noncoding RNAs as Pharmacological Targets in Neurological Diseases (Deadline: 22 June 2024)
- New Insights into Therapy for Alzheimer’s and Other Neurodegenerative Diseases (Deadline: 22 June 2024)
- Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention (Deadline: 25 June 2024)
- Toxicological Effects of Drug Abuse and Its Consequences on Health (Deadline: 25 June 2024)
- Combining Immunotherapy and Targeted Therapies in Cancer Treatment (Deadline: 25 June 2024)
- Purinergic Signaling: A New Pharmacological Target (Deadline: 25 June 2024)
- Pharmacological Treatments for Melanoma (Deadline: 25 June 2024)
- Targeted Therapies for Epilepsy (Deadline: 25 June 2024)
- Barrier Dynamics and Immune Interplay in Brain Aging and Injury (Deadline: 25 June 2024)
- Drug Analysis and Therapeutic Drug Monitoring (Deadline: 25 June 2024)
- Drug-Drug Interactions (DDI) and Personalized Medicine in Oncology (Deadline: 25 June 2024)
- Therapeutic Drug Monitoring and Adverse Drug Reactions (Deadline: 29 June 2024)
- Population Pharmacokinetic and Pharmacodynamics (Deadline: 30 June 2024)
- Pharmacological Advances for Treatment in Hypertension 2.0 (Deadline: 30 June 2024)
- Therapeutic Agents for Neurological Disorders 2023 (Deadline: 30 June 2024)
- Advances in Pharmacotherapy of Neuropathic Pain (Deadline: 30 June 2024)
- Application of Gastrointestinal Peptides in Medicine (Deadline: 5 July 2024)
- 20th Anniversary of Pharmaceuticals—Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma (Deadline: 15 July 2024)
- Kynurenine Pathway: A Novel Therapeutic Opportunity (Deadline: 15 July 2024)
- Pharmacological Insight into NMDA Receptor Antagonists (Deadline: 15 July 2024)
- A Commemorative Special Issue in Honor of Prof. Jolanta Saczko: Pharmaceutical Science in Electrochemotherapy (Deadline: 15 July 2024)
- Cancer Chemoradiotherapy (Deadline: 20 July 2024)
- Insights into Vitamin E Therapy (Deadline: 20 July 2024)
- Transient Receptor Potential (TRP) Channels as Novel Therapeutic Targets (Deadline: 20 July 2024)
- Pharmacological Therapies for Stress-Related Disorders and Autism Spectrum Disorder (Deadline: 21 July 2024)
- Multi-target Drug Treatments for Neurodegenerative Disease (Deadline: 22 July 2024)
- Psychiatric Drug Treatment and Drug Addiction (Deadline: 23 July 2024)
- Gut Microbiota Metabolites in Intestinal Inflammation and Fibrosis (Deadline: 25 July 2024)
- Smooth Muscle and Endothelial Cells as Pharmacological Targets for Acute Oxidative Stress (Deadline: 25 July 2024)
- Advances in Mass Spectrometry Metrology in Pharmaceutical Sciences (Deadline: 25 July 2024)
- Dopamine and Serotonin Receptors: Selective or Multitarget Ligands for the Treatment of Central Nervous System Diseases (Deadline: 25 July 2024)
- Neuroblastoma Pathogenesis and Therapy (Deadline: 25 July 2024)
- Therapeutic Strategies and Targets to Improve the Efficacy of PD-1/PD-L1 Blockade (Deadline: 25 July 2024)
- Pharmacological Modulation of Lipoproteins (Deadline: 26 July 2024)
- Adjuvant Therapies for Cancer Treatment (Deadline: 26 July 2024)
- HNSCC Chemotherapy: What We Know and New Perspectives (Deadline: 31 July 2024)
- Ophthalmic Pharmacology (Deadline: 6 August 2024)
- Melatonin in Cancer Treatment (Deadline: 10 August 2024)
- Optimized or Precise Pharmacological Treatment of Bipolar Disorder (Deadline: 15 August 2024)
- Calcium Channels as Therapeutic Targets (Deadline: 15 August 2024)
- Small Molecules in Targeted Cancer Therapy and Diagnosis (Deadline: 20 August 2024)
- Oncolytic Viruses: New Cancer Immunotherapy Drugs (Deadline: 25 August 2024)
- Population Pharmacokinetic and Pharmacodynamic and Clinical Strategies (Deadline: 25 August 2024)
- Rodent Animal Models for Drug Discovery (Deadline: 25 August 2024)
- Drug Candidates for the Treatment of Atopic Dermatitis (Deadline: 25 August 2024)
- Pharmacotherapy of Thromboembolism (Deadline: 31 August 2024)
- Tumor Immunopharmacology (Deadline: 9 September 2024)
- Affective Disorders Psychopharmacology (Deadline: 20 September 2024)
- Drug Candidates for Allergic Diseases (Deadline: 20 September 2024)
- Ion Channel Pharmacology (Deadline: 22 September 2024)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement (Deadline: 25 September 2024)
- Pharmacotherapy for Macular Diseases 2024 (Deadline: 25 September 2024)
- Advances in Neuropharmacology of Drug Abuse (Deadline: 25 September 2024)
- 20th Anniversary of Pharmaceuticals—Met Receptor (Deadline: 25 September 2024)
- Drug Resistance Against Cancer Treatment (Deadline: 25 September 2024)
- Medications: Interactions with Diet, Herbs, Dietary Supplements and Probiotics (Deadline: 27 September 2024)
- Drug Safety and Risk Management in Clinical Practice (Deadline: 30 September 2024)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy (Deadline: 30 September 2024)
- Membrane Transporters in Drug Development: Recent Advances (Deadline: 13 October 2024)
- Novel Antimicrobials and the Antimicrobial Activity: New Advances (Deadline: 25 October 2024)
- Pharmacotherapy for Alzheimer’s Disease (Deadline: 30 October 2024)
- Fluoroquinolones (Deadline: 31 October 2024)
- DHA and EPA in Health and Disease (Deadline: 31 October 2024)
- Exploring Biomarkers and Pharmacotherapies for Substance Use Disorders (Deadline: 25 November 2024)
- Pharmacotherapy for Schizophrenia: New Advances (Deadline: 22 December 2024)
- Biomarkers and Therapeutic Targets for Melanoma (Deadline: 31 December 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
